CID 137279257

Tinengotinib

Structural Information

Molecular Formula
C20H19ClN6O
SMILES
CC1=C2C(=NN1)NC3=CC(=NC=C3C(=N2)C4=CC=CC=C4Cl)N5CCOCC5
InChI
InChI=1S/C20H19ClN6O/c1-12-18-20(26-25-12)23-16-10-17(27-6-8-28-9-7-27)22-11-14(16)19(24-18)13-4-2-3-5-15(13)21/h2-5,10-11H,6-9H2,1H3,(H2,23,25,26)
InChIKey
DQFCVOOFMXEPOC-UHFFFAOYSA-N
Compound name
4-[9-(2-chlorophenyl)-6-methyl-2,4,5,8,12-pentazatricyclo[8.4.0.03,7]tetradeca-1(14),3,6,8,10,12-hexaen-13-yl]morpholine
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

47
Patents

394.1309 Da
Monoisotopic Mass

3.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 395.13818 196.0
[M+Na]+ 417.12012 206.0
[M-H]- 393.12362 198.9
[M+NH4]+ 412.16472 200.7
[M+K]+ 433.09406 200.7
[M+H-H2O]+ 377.12816 181.2
[M+HCOO]- 439.12910 199.4
[M+CH3COO]- 453.14475 202.4
[M+Na-2H]- 415.10557 196.9
[M]+ 394.13035 191.2
[M]- 394.13145 191.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe